GP Strategies (GP Strategies) Risk Assessment

View and export this data going back to 1972. Start your Free Trial

What is GP Strategies Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of GP Strategies is: No Data: Cannot be evaluated.

Competitive Comparison of GP Strategies's Risk Assessment

For the Education & Training Services subindustry, GP Strategies's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GP Strategies's Risk Assessment Distribution in the Education Industry

For the Education industry and Consumer Defensive sector, GP Strategies's Risk Assessment distribution charts can be found below:

* The bar in red indicates where GP Strategies's Risk Assessment falls into.

GP Strategies (NYSE:GPX) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

GP Strategies Risk Assessment Related Terms

Thank you for viewing the detailed overview of GP Strategies's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

GP Strategies (GP Strategies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » GP Strategies Corp (NYSE:GPX) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

70 Corporate Center, Suite 300, 11000 Broken Land Parkway, Columbia, MD, USA, 21044

Website

https://www.gpstrategies.com

GP Strategies Corp provides training, e-Learning solutions, management consulting, and engineering services. The company serves companies in the automotive, financial services and insurance, steel, oil and gas, power, chemical, electronics and technology, manufacturing, software, retail, healthcare, education, and food and beverage industries, as well as government agencies. Its training offerings include content and curriculum development, e-Learning, learning and training outsourcing, and documentation development.

Executives

Pfenniger Richard C Jr	director	4400 BISCAYNE BLVD., MIAMI FL 33137
Marshall S Geller	director	10866 WILSHIRE BLVD., SUITE 1450, LOS ANGELES CA 90024
Tamar Elkeles	director	1040 MUIRLANDS DRIVE LA JOLLA CA 92037
Samuel D. Robinson	director	C/O SAGARD CAPITAL MGMT. CORPORATION 325 GREENWICH AVENUE GREENWICH CT 06830
Steven Elliot Koonin	director	1535 RANCHO CONEJO BLVD THOUSAND OAKS CA 91320
Jacques Manardo	director
Adam H Stedham	officer: CEO & President	GP STRATEGIES CORPORATION, 11000 BROKEN LAND PARKWAY, SUITE 200, COLUMBIA MD 21044
James L Galante	officer: SVP & General Counsel	GP STRATEGIES CORPORATION 11000 BROKEN LAND PARKWAY SUITE 200 COLUMBIA MD 21044
Scott N Greenberg	director	9 WEST 57 STREET, SUITE 4170, NEW YORK NY 10019
Russell L. Becker	officer: EVP, Chief Sales Officer	GP STRATEGIES CORPORATION 11000 BROKEN LAND PKWY, SUITE 200 COLUMBIA MD 21044
Michael R Dugan	officer: EVP & Chief Financial Officer	GP STRATEGIES CORPORATION 11000 BROKEN LAND PARKWAY, SUITE 200 COLUMBIA MD 21044
Donald R Duquette	officer: Executive Vice President	6095 MARSHALEE DRIVE SUITE 300 ELKRIDGE MD 21075
Patricia R. Begley	officer: Executive Vice President	GP STRATEGIES CORPORATION 6095 MARSHALEE DR., SUITE 300 ELKRIDGE MD 21075
Kenneth L Crawford	officer: EVP & General Counsel	6095 MARSHALEE DRIVE SUITE 300 ELKRIDGE MD 21075
Cove Street Capital, Llc	10 percent owner	525 SOUTH DOUGLAS STREET, SUITE 225, EL SEGUNDO CA 90245